register now
get brochure
add event to diary
email this to...
contact us
Breakthrough
Contact LIVE

conference details
 
Conference:
Day 1
17 March 2010 8am - 5:30pm
Day 2
18 March 2010 8am - 5:30pm

› More about the conference
› Add this to my calendar

Register online now
or call +65 6322 2701

 

 

 

Dr Dai Hongyue, speaking at Drug Discovery Technology World Asia 2010

Dr Dai Hongyue,
Senior Scientific Director, Molecular Profiling Data Analysis, Molecular Profiling Research Informatics
Merck Research Labs, United States

Hongyue Dai currently holds the Senior Scientific Director position of Molecular Profiling Data Analysis In Molecular Profiling Research Informatics of Merck Research Labs. His responsibilities include managing the molecular profiling data analysis support to various therapeutic franchises within Merck for target identification, biomarker discovery, compound prioritization and translating biomarkers in clinical trials. His current research interest is to use molecular profiling to study cancer. He joined Rosetta in January of 1998 as a senior data analyst. In the early days of Rosetta, he worked closely with the biologists and engineers to develop and improve the inkjet microarray platform. He identified numerous artifacts related to microarray and sample handling processes and worked with the technology team to minimize the systematic biases. He also co-developed the first microarray data error model to characterize the data uncertainty. His most recent publications are cancer research related, including a Nature and a NEJM publication on breast cancer prognosis, a follow up data analysis on Cancer Research about breast cancer patient stratification, and a PNAS publication about CML disease progression. He made significant contribution to the first FDA approved multi-gene test kit for breast cancer prognosis, the MammaPrint. He also collaborated with Celera to develop the 14-gene test kit for ER-positive breast cancer patients. He was a Research Associate Professor of Physics Department at University of Utah before joining Rosetta. He earned his credit as a solid data analyst by convincingly proving to the high energy astrophysics world the existence of cosmic rays beyond the 3oK microwave cutoff energy, through the discovery and careful analysis of a single event (It was commonly accepted that the microwave background eliminates all those cosmic rays). His analysis results about the cosmic ray energy spectrum and composition were published in Physical Review Letters and were widely cited. He received his BS from Peking University and PhD from Institute of High Energy Physics of Chinese Academy of Science.
Appearing:
Conference Day One: Wednesday, 17 March 2010
14.30

Molecular analysis of tumor and adjacent tissues to identify HCC targets

Dr Dai Hongyue,
Senior Scientific Director, Molecular Profiling Data Analysis, Molecular Profiling Research Informatics,
Merck Research Labs, United States
part of:

event sponsors
Session sponsor:
 
Exhibitors:
 
 
 

asia research institution poster presentation


Present a poster and get free passes* to attend Drug Discovery Technology World Asia 2010 symposium and Pharma R&D Partnering World Asia 2010!
 
* For first 20 confirmed poster presentations

sponsorship opportunities
Drug Discovery Technology World Asia 2010 is your gateway to doing business with people who can make procurement decisions in the booming industry of Asia!
 
Demonstrate your thought leadership, reinforce with proven case studies, put forward your lead scientists and associate your brand with the industry’s FIRST and BEST forum to discuss challenges, solutions, best practices and business opportunities!
 
 
Target your market!
 
Contact us for details
 


comment / report a mistake | contact us | about Terrapinn | site map | privacy | T&Cs a terrapin ©Terrapinn Holdings Ltd. MMX